AlphaFold predicted structure
SMG9 · Q9H0W8

Mean pLDDT
70.6/ 100
Confident
520 residues
Confidence breakdown
- Very high(≥ 90)37%
- Confident(70–90)20%
- Low(50–70)6%
- Very low(< 50)37%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
SMG9 nonsense mediated mRNA decay factor
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalClefting
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalStructural eye disease
BIALLELIC, autosomal or pseudoautosomalAutosomal dominant deafness-onychodystrophy syndrome
neurodevelopmental disorder with intention tremor, pyramidal signs, dyspraxia, and ocular anomalies
hereditary disease
Global developmental delay
Abnormal cardiovascular system morphology
Abnormal facial shape
autism spectrum disorder
Brainstem dysplasia
Neurodevelopmental abnormality
glioma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Nonsense-mediated mRNA decay factor SMG9
Involved in nonsense-mediated decay (NMD) of mRNAs containing premature stop codons (PubMed:19417104). Is recruited by release factors to stalled ribosomes together with SMG1 and SMG8 (forming the SMG1C protein kinase complex) and, in the SMG1C complex, is required for the efficient association between SMG1 and SMG8 (PubMed:19417104). Plays a role in brain, heart, and eye development (By similarity)
SMG9 · Q9H0W8

Mean pLDDT
70.6/ 100
Confident
520 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0